Related Articles
Statin use improves the prognosis of ovarian cancer: An updated and comprehensive meta‑analysis
Cancer cachexia as a determinant of efficacy of first‑line pembrolizumab in patients with advanced non‑small cell lung cancer
Assessment of prognostic factors in previously treated Japanese patients with metastatic renal cell carcinoma who received nivolumab: An observational multi‑institute study
Survival‑associated factors of first‑line EGFR‑tyrosine kinase inhibitor responders and non‑responders in lung adenocarcinoma patients with common EGFR mutations
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status